Tonix Pharmaceuticals Holding Corp. (TNXP)
8.91
-0.32
(-3.47%)
USD |
NASDAQ |
Oct 02, 16:00
8.85
-0.06
(-0.67%)
After-Hours: 20:00
Tonix Pharmaceuticals Gross Profit Margin (Quarterly) : 90.24% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 90.24% |
| March 31, 2026 | 68.99% |
| December 31, 2025 | 71.32% |
| September 30, 2025 | 44.44% |
| June 30, 2025 | -87.94% |
| March 31, 2025 | 40.88% |
| Date | Value |
|---|---|
| December 31, 2024 | 34.97% |
| September 30, 2024 | 27.18% |
| June 30, 2024 | -107.1% |
| March 31, 2024 | -15.63% |
| December 31, 2023 | -2.09% |
| September 30, 2023 | 15.97% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | -- |
| Nektar Therapeutics | 98.46% |
| Heron Therapeutics, Inc. | 69.28% |
| ACADIA Pharmaceuticals, Inc. | 90.81% |
| Alnylam Pharmaceuticals, Inc. | 76.88% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -72.99% |
| Return on Assets | -64.96% |
| Return on Invested Capital | -72.67% |
| Profit Margin (Quarterly) | -299.4% |
| Operating Margin (Quarterly) | -314.1% |
| Return on Net Operating Assets | -258.9% |